Alphabet Inc. - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 43 filers reported holding EVELO BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Alphabet Inc. ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$190,889
-88.8%
1,060,4950.0%0.01%
-88.9%
Q4 2022$1,707,397
-23.0%
1,060,4950.0%0.10%
-12.4%
Q3 2022$2,216,000
-1.0%
1,060,4950.0%0.11%
-6.6%
Q2 2022$2,238,000
-37.7%
1,060,4950.0%0.12%
+3.4%
Q1 2022$3,595,000
-44.2%
1,060,4950.0%0.12%
-24.5%
Q4 2021$6,437,000
-13.8%
1,060,4950.0%0.16%
-12.4%
Q3 2021$7,466,000
-48.8%
1,060,4950.0%0.18%
-40.4%
Q2 2021$14,571,000
+28.4%
1,060,4950.0%0.30%
-35.0%
Q1 2021$11,347,000
-11.5%
1,060,4950.0%0.46%
-25.7%
Q4 2020$12,821,000
+129.4%
1,060,4950.0%0.62%
+133.8%
Q3 2020$5,589,000
+7.6%
1,060,4950.0%0.26%
+9.6%
Q2 2020$5,196,000
+30.5%
1,060,4950.0%0.24%
-8.0%
Q1 2020$3,982,000
-7.5%
1,060,4950.0%0.26%
+0.4%
Q4 2019$4,306,000
-33.4%
1,060,4950.0%0.26%
+34.0%
Q3 2019$6,469,000
-32.1%
1,060,4950.0%0.19%
+7.2%
Q2 2019$9,523,000
+12.2%
1,060,4950.0%0.18%
-58.7%
Q1 2019$8,484,000
-38.5%
1,060,4950.0%0.44%
-73.1%
Q4 2018$13,797,000
+6.8%
1,060,4950.0%1.63%
+31.9%
Q3 2018$12,917,000
+3.2%
1,060,4950.0%1.24%
+17.7%
Q2 2018$12,514,0001,060,4951.05%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 18,233,403$145,867,0005.52%
HARBOURVEST PARTNERS LLC 1,763,505$14,108,0004.99%
Samsara BioCapital, LLC 227,529$1,820,0001.43%
SECTORAL ASSET MANAGEMENT INC 651,077$5,209,0000.63%
Alphabet Inc. 1,060,495$8,484,0000.44%
Larson Financial Group LLC 7,268$58,0000.05%
CREDIT SUISSE AG/ 1,103,763$8,830,0000.01%
FMR LLC 3,325,107$26,601,0000.00%
VICTORY CAPITAL MANAGEMENT INC 87,370$699,0000.00%
Tower Research Capital LLC (TRC) 4,750$38,0000.00%
View complete list of EVELO BIOSCIENCES INC shareholders